[go: up one dir, main page]

LV10452B - A process for the preparation of (1h-azolo-1-ylmethyl)-substituted derivatives of benzotriazoles - Google Patents

A process for the preparation of (1h-azolo-1-ylmethyl)-substituted derivatives of benzotriazoles Download PDF

Info

Publication number
LV10452B
LV10452B LVP-92-233A LV920233A LV10452B LV 10452 B LV10452 B LV 10452B LV 920233 A LV920233 A LV 920233A LV 10452 B LV10452 B LV 10452B
Authority
LV
Latvia
Prior art keywords
formula
compound
alkyl
cmecb
npn
Prior art date
Application number
LVP-92-233A
Other languages
English (en)
Latvian (lv)
Other versions
LV10452A (lv
Inventor
Alfons H M Raeymaekers
Eddy J E Freyne
Gelder Josephus L H Van
Marc G Venet
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of LV10452A publication Critical patent/LV10452A/xx
Publication of LV10452B publication Critical patent/LV10452B/lv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
LVP-92-233A 1987-06-01 1992-11-27 A process for the preparation of (1h-azolo-1-ylmethyl)-substituted derivatives of benzotriazoles LV10452B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5602187A 1987-06-01 1987-06-01

Publications (2)

Publication Number Publication Date
LV10452A LV10452A (lv) 1995-02-20
LV10452B true LV10452B (en) 1995-08-20

Family

ID=22001654

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-233A LV10452B (en) 1987-06-01 1992-11-27 A process for the preparation of (1h-azolo-1-ylmethyl)-substituted derivatives of benzotriazoles

Country Status (24)

Country Link
EP (1) EP0293978B1 (bg)
JP (1) JPH0662612B2 (bg)
KR (1) KR970000952B1 (bg)
CN (1) CN1022184C (bg)
AU (1) AU603446B2 (bg)
BG (2) BG50278A3 (bg)
CA (1) CA1307271C (bg)
CY (1) CY1866A (bg)
DE (1) DE3884055T2 (bg)
DK (1) DK175218B1 (bg)
ES (1) ES2059490T3 (bg)
FI (1) FI90078C (bg)
HK (1) HK114795A (bg)
HU (2) HU201056B (bg)
IE (1) IE61823B1 (bg)
IL (1) IL86551A (bg)
LT (1) LT3950B (bg)
LV (1) LV10452B (bg)
NO (1) NO169900C (bg)
NZ (1) NZ224714A (bg)
PT (1) PT87623B (bg)
RU (1) RU1838308C (bg)
UA (1) UA11192A (bg)
ZA (1) ZA883861B (bg)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827820D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
CA2002859C (en) * 1988-11-29 1998-12-29 Jean P. F. Van Wauwe Method of treating epithelial disorders
US5157046A (en) * 1988-11-29 1992-10-20 Janssen Pharmaceutica N.V. Method of treating epithelial disorders
EP0408509B1 (de) * 1989-07-14 1996-03-06 Ciba-Geigy Ag Substituierte Benzonitrile
US5066656A (en) * 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
CA2026792A1 (en) * 1989-11-01 1991-05-02 Michael N. Greco (6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1h-benzotriazole derivatives
NZ236440A (en) * 1989-12-15 1993-07-27 Merck & Co Inc Reversal of sexual phenotype in poultry using an inhibitor of steroid biotransformation and/or aromatase inhibitor, poultry produced by this process
AU7124691A (en) * 1990-02-27 1991-08-29 Ciba-Geigy Ag Benzofurans
DE4010797A1 (de) * 1990-04-04 1991-10-10 Hoechst Ag Substituierte azole, verfahren zu deren herstellung, diese enthaltende mittel und deren verwendung
EP0457716A1 (de) * 1990-04-20 1991-11-21 Ciba-Geigy Ag Naphthalinderivate
TW224461B (bg) * 1990-09-18 1994-06-01 Ciba Geigy Ag
US5162337A (en) * 1990-10-05 1992-11-10 Merck & Co., Inc. Animal growth promotion
TW210334B (bg) * 1990-12-12 1993-08-01 Ciba Geigy Ag
CH683151A5 (de) * 1991-04-24 1994-01-31 Ciba Geigy Ag Antikonzeption bei weiblichen Primaten ohne Beeinflussung des menstruellen Zyklus.
CA2116773C (en) 1991-09-02 2002-12-10 Minoru Okada Triazolylated tertiary amine compound or salt thereof
US5635521A (en) * 1991-09-23 1997-06-03 Sandoz Ltd. Imidazolylmethyl-pyridines
JP2700595B2 (ja) * 1992-05-21 1998-01-21 呉羽化学工業株式会社 アゾール誘導体を含有する抗アロマターゼ剤
CA2148489A1 (en) * 1992-11-10 1994-05-26 Albert Louis Anna Willemsens Process for preparing enantiomerically pure 6-¬(4-chlorophenyl)(1h-1,2,4-triazol-1-yl) methyl|-1-methyl-1h
CA2150326A1 (en) * 1994-05-27 1995-11-28 Kimihiro Murakami Azolyl methyl phenyl derivatives having aromatase inhibitory activity
AU6821196A (en) * 1995-08-14 1997-03-12 Janssen Pharmaceutica N.V. Transdermal administration of vorozole
IT1286866B1 (it) * 1996-10-28 1998-07-17 Menarini Farma Ind Composti furano-eterociclici,loro preparazione ed uso come inibitori di aromatasi
EP0949242A4 (en) * 1996-12-24 2004-09-08 Chugai Seiyakukabushiki Kaisha AROMATIC AMINE DERIVATIVES HAVING AN INHIBITORY ACTION WITH RESPECT TO OUR
AU2001264223A1 (en) * 2000-06-28 2002-01-08 Ssp Co., Ltd. Imidazole derivatives or salts thereof and drugs containing the derivatives or the salts
CA2517517C (en) * 2003-03-03 2012-12-18 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
US7135575B2 (en) 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
US20090036435A1 (en) 2005-01-21 2009-02-05 Astex Therapeutics Limited Pharmaceutical Compounds
JP5137816B2 (ja) * 2005-04-29 2013-02-06 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ カンナビノイド受容体アンタゴニストとしてのベンゾトリアゾール誘導体
US7572807B2 (en) 2005-06-09 2009-08-11 Bristol-Myers Squibb Company Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
US8361996B2 (en) 2005-09-15 2013-01-29 Council Of Scientific And Industrial Research Imidazolyl substituted steroidal and indan-1-one derivatives
BRPI0707401B8 (pt) 2006-01-31 2022-12-20 Array Biopharma Inc compostos inibidores de cinase, composição farmacêutica, processo para a preparação e usos dos referidos compostos ou de um pró-fármaco de um composto
US8883790B2 (en) 2006-10-12 2014-11-11 Astex Therapeutics Limited Pharmaceutical combinations
EP2073803B1 (en) 2006-10-12 2018-09-19 Astex Therapeutics Limited Pharmaceutical combinations
WO2012052540A1 (en) * 2010-10-21 2012-04-26 Universitaet Des Saarlandes Selective cyp11b1 inhibitors for the treatment of cortisol dependent diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR75101B (bg) * 1980-10-23 1984-07-13 Pfizer
US4659730A (en) * 1984-06-18 1987-04-21 Eli Lilly And Company Aromatase inhibiting imidazole derivatives
US4609666A (en) * 1984-06-18 1986-09-02 Eli Lilly And Company Aromatase inhibiting derivatives of α,α-bis(4-halophenyl)methyltetrazoles and triazoles
US4801594A (en) * 1984-06-18 1989-01-31 Eli Lilly And Company Aromatase inhibitors
US4602025A (en) * 1984-06-18 1986-07-22 Eli Lilly And Company Aromatase inhibitors
EP0165781A1 (en) * 1984-06-18 1985-12-27 Eli Lilly And Company Aromatase inhibiting N-substituted imidazole derivatives
DE3744589C1 (de) 1987-12-31 1988-12-29 Albrecht Josef Bohrfutter Nachspannendes Bohrfutter

Also Published As

Publication number Publication date
UA11192A (uk) 1996-12-25
DE3884055D1 (de) 1993-10-21
AU1653788A (en) 1988-12-01
DK175218B1 (da) 2004-07-12
IE881640L (en) 1988-12-01
NO169900C (no) 1992-08-19
BG60429B2 (bg) 1995-03-31
CN1022184C (zh) 1993-09-22
KR970000952B1 (ko) 1997-01-21
HU211482A9 (en) 1995-11-28
DK295288D0 (da) 1988-05-31
EP0293978B1 (en) 1993-09-15
CN88103408A (zh) 1988-12-14
PT87623B (pt) 1992-09-30
EP0293978A3 (en) 1990-06-13
PT87623A (pt) 1988-06-01
KR890000469A (ko) 1989-03-14
RU1838308C (ru) 1993-08-30
CA1307271C (en) 1992-09-08
NO882390D0 (no) 1988-05-31
FI882552A (fi) 1988-12-02
FI882552A0 (fi) 1988-05-31
LTIP1625A (en) 1995-07-25
NO882390L (no) 1988-12-02
IE61823B1 (en) 1994-11-30
HU201056B (en) 1990-09-28
DE3884055T2 (de) 1994-01-27
NO169900B (no) 1992-05-11
JPS63316775A (ja) 1988-12-26
LT3950B (en) 1996-05-27
NZ224714A (en) 1990-03-27
AU603446B2 (en) 1990-11-15
CY1866A (en) 1988-05-26
HK114795A (en) 1995-07-21
LV10452A (lv) 1995-02-20
FI90078B (fi) 1993-09-15
ES2059490T3 (es) 1994-11-16
HUT49132A (en) 1989-08-28
ZA883861B (en) 1990-01-31
IL86551A0 (en) 1988-11-15
IL86551A (en) 1992-07-15
EP0293978A2 (en) 1988-12-07
BG50278A3 (bg) 1992-06-15
JPH0662612B2 (ja) 1994-08-17
FI90078C (fi) 1993-12-27
DK295288A (da) 1988-12-02

Similar Documents

Publication Publication Date Title
LV10452B (en) A process for the preparation of (1h-azolo-1-ylmethyl)-substituted derivatives of benzotriazoles
KR101034489B1 (ko) 2-아미노-4,5-삼치환 티아졸릴 유도체
ES2298513T3 (es) Derivados de tiazol como antagonistas del receptor de taquicinina.
EP1339711B1 (en) Aminothiazoles and their use as adenosine receptor antagonists
EP1513837B1 (de) Thiazolderivate als phosphodiesterase iv-inhibtoren
ES2281801T3 (es) Inhibidores benzamida del receptor p2x7.
CN102762542B (zh) 一种抗真菌三唑衍生物
RU2004122924A (ru) Пирролпиримидины в качестве ингибиторов фосфодиэстеразы v11
JP4944954B2 (ja) ホスファチジルイノシトール3−キナーゼ阻害剤としてのチアゾリルウレア誘導体
RU97119064A (ru) Применение альфа(il)-агонистов для лечения недержания мочи
JP2008512490A5 (bg)
KR20020062298A (ko) N-치환된 카바모일옥시알킬-아졸리움 유도체
CA2537127A1 (en) Benzimidazolone compounds having 5-ht4 receptor agonistic activity
CA2409741A1 (en) Tnf-.alpha. production inhibitors
ZA200404387B (en) Hydrazono-malonitriles.
CA2539297A1 (en) Substituted triazole derivatives as oxytocin antagonists
DE2712160A1 (de) Pseudotrisaccharide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
JP2004509863A (ja) コルチコトロピン放出因子のインヒビターとしての置換アゾール誘導体
CA2632444A1 (en) Use of aminoalcohol derivatives for the treatment of overactive bladder
US7534795B2 (en) Compounds and their use related to compositions for treating disease
US4710498A (en) Pyridyloxy derivatives
NZ334477A (en) Amino acid ester containing azole antifungals
CA1209998A (en) Amide derivatives as histamine h-2 receptor antagonists
WO2003007939A1 (en) Azetidine derivatives and their use as ccr3 receptor antagonists
AU2004216858B2 (en) Pyridylsulfonamido pyrimidines for treating diabetic nephropathy